more, adverse effects of serum components on embryos are Adelaide, South Australia possible (Jinno et al., 1987) . There are also clinical situations 3 To whom correspondence should be addressed where the use of serum from the female partner may be Over a 26 month period 17% of couples having treatment in contraindicated (i.e. women with antisperm antibodies or our clinical programmes selected a commercially available contaminating agents or pathogens), or obtaining serum is protein (normal serum albumin, NSA) prepared from difficult for either technical or logistic reasons. In addition the pooled human sera instead of using their own serum as a time required to collect and process sera from individual supplement for their embryo culture media. In a retrospectcouples is not insignificant in a busy clinic. Consequently, ive analysis of Ͼ2000 gonadotrophin-stimulated cycles and there are advantages in using defined sources of protein to 1000 cycles where frozen/thawed embryos were transferred, supplement culture media and commercially available lyophilfertilization, embryo quality and pregnancy rates following ized protein fractions purified from pooled sera or complete in-vitro fertilization (IVF), gamete intra-Fallopian transfer media supplemented with an albumin enriched fraction are (GIFT) or intracytoplasmic sperm injection (ICSI) were now widely used. The level of serum supplementation is unaffected by the type of protein used to supplement the typically 7.5-15%, but different concentrations of protein culture medium. When embryos were thawed in medium are often used for the oocyte recovery, sperm preparation, containing NSA, both pregnancy (PR) and implantation fertilization, embryo culture and embryo transfer. Our clinical rates (IR) were significantly lower (P Ͻ0.05) than if the programmes routinely utilize 5% serum in all culture media medium was supplemented with serum (PR 8.3% and and 50% for embryo transfer after it was shown that reducing 17.5%; IR 4.6% and 10.5%). Inclusion of NSA before the concentration of serum in the culture media did not affect freezing reduced the IR of thawed embryos. To further treatment outcome and reduced the total amount of serum test this observation all cycles where embryos were cultured needed to treat each couple (unpublished data). and frozen in medium containing NSA (173 cycles) were
When pregnancy or implantation rates following transfer of matched to cycles where serum was used and the outcome embryos cultured in media with different protein supplements was compared. At the end of 1995 just over half of the have been compared, the results have been variable. Isotonic embryos in both groups had been thawed. No statistical protein supplements for intravenous infusion are prepared from difference was noted in the pregnancy rates (NSA, 5.6% pooled human plasma and are available as 5% or 20% (w/v) versus serum, 11.3%) but the IR per embryo was significsterile solutions. One commercially available protein suppleantly lower when embryos were cultured and frozen in ment (Albuminar-Armour Pharmaceuticals) has been used in medium supplemented with NSA (2.2%) than when serum a number of published trials. Ashwood-Smith et al. (1989) was used as the supplement (6.6%). found no effect of Albuminar-5 compared with serum, Staessen Key words: cryopreservation/frozen embryos/normal serum et al. (1990) obtained superior results with Albuminar-20 albumin/thawed embryos compared to serum and Hargreaves et al. (1995) reported higher pregnancy rates with serum than Albuminar-5. Other studies comparing treatment outcomes when highly purified protein fractions are used to supplement the culture media Introduction have tended to show either no effect or an improvement in outcome (Ménézo et al., 1984; Holst et al., 1990; Adler et al., In human assisted reproduction programmes, different culture systems are used with apparently equal success and a number 1993). At present, there is no clear evidence for superiority of any one type of medium with respect to treatment outcome, of media of varying chemical composition are commonly used. Although the successful fertilization and culture of human with several media of different composition being commonly used for assisted reproduction treatment. zygotes in protein-free media have been reported (Caro and Trounson, 1986) , protein is usually a component of the media.
Human embryos have been successfully frozen using a number of freezing protocols and several studies have Autologous female serum remains the most common source of protein supplement, but follicular fluid, amniotic fluid, attempted to assess whether freezing affects the viability of good quality embryos (see Selick et al., 1995) . While there pooled cord sera and fractions purified from both human and cycle or had a clomiphene citrate/human chorionic gonadotrophin are differences in both the media and cryoprotectant used (HCG) cycle. Thaw time was determined to within 12 h of the in published human freezing protocols, effects of protein developmental stage of the embryos at the time of freezing with supplement on the outcome following the transfer of cryoblood hormone concentrations used to detect the onset of the preserved embryos has not been systematically reported.
luteinizing hormone (LH) surge in ovular cycles (Wang et al., 1994) .
Commencing in November 1993, we offered all couples Embryos which were thawed in the afternoon were cultured overnight attending our two clinics the choice of using normal serum before being transferred, while embryos from morning thaws were albumin (NSA) as an alternative to autologous female serum serum, and the effect of this choice on the outcome following A clinical pregnancy was defined by the presence of a gestational transfer of both fresh and cryopreserved embryos is reported.
sac on ultrasound and the number of sacs seen was used to calculate implantation rates. Clinical pregnancy rates are expressed per embryo transfer.
Materials and methods

All patients receiving assisted reproduction treatment in programmes
Statistical methods at either of our two clinics were offered the choice of using either
The results of all stimulated cycles from two clinical programmes normal serum albumin (NSA) or autologous serum (serum) to and all frozen embryo cycles from the time when NSA was first used supplement their culture media. Informed voluntary consent from all until December 1995 were included in the analyses. Chi square patients and annual reporting of the results was a condition of our analysis or Fisher's exact test was used for the analyses depending Institutional Ethics Committee in granting approval to use NSA.
on the number of observations in the treatment groups. One or more From 1995, all couples where either partner had positive serum embryos were frozen in 173 cycles where NSA had been used for antibodies to hepatitis B or C were assigned to using NSA in their the culture and freezing media; since the study was non-randomized culture media. In our treatment programmes, Ͻ2% of couples were and retrospective, these cycles were paired to the chronologically affected by this change in policy.
nearest cycle meeting standard criteria (Adler et al., 1993) . Matching NSA (5%) was obtained from the Commonwealth Serum Laboratfor type of treatment [IVF, gamete intra-Fallopian transfer (GIFT) or ories (Melbourne, Australia). Each 500 ml bottle was dispensed ICSI] and treatment outcome (clinical pregnancy) was absolute, with aseptically into 50 ml culture bottles and stored at 4°C until required. a best possible matching for female age, the number of embryos Blood was collected from the female partner on day 9 or 10 of the frozen and the number of previous treatment cycles, in descending treatment cycle and the serum was heat inactivated at 56°C for 35 min priority. However, female age was only considered when Ͼ35 years and stored at 4°C until required. All sera were prepared aseptically of age at the time of treatment. Where the cycles had a low frequency and were not filter sterilized. Sera which were visibly lipaemic or in the data set (e.g. a 40 year old patient who was pregnant following haemolysed, or if the oocyte recovery or thaw had not occurred ICSI and had eight embryos frozen) it was necessary to extend the within 7 days, were discarded and fresh serum prepared. Human chronological separation to identify a suitable control cycle. Pairing tubal fluid medium (prepared in our own laboratories) was used was performed by a staff member not directly involved in the study throughout the study period; both bicarbonate and HEPES buffered and the outcome for all embryos thawed until the end of 1995 in media were made monthly from stocks (Quinn et al., 1984) . All both groups was compared. culture media were supplemented to 5% (v/v) with either maternal serum or NSA; the embryo transfer medium was supplemented to 50% (v/v). Media were pre-equilibrated overnight before use; bicarbonate buffered media in an atmosphere of 5% CO 2 in air and
Results
HEPES buffered media in an air incubator. Incubator temperatures
During the study period, acceptance of NSA by patients for were maintained at 37.2°C. oocyte recovery cycles (16% of all cycles) and frozen embryo Implantation rates between groups were also significantly c Includes cycles where NSA or serum may have been used for the cycle where the embryos were frozen. different (Table IIIb) . Embryos cultured and frozen in medium d Protein supplement in thawing medium.
containing NSA were significantly less likely to implant than those cultured and frozen in serum (P Ͻ0.0001). The highest implantation rate (10.9%) occurred when serum was used for tion rate per oocyte or embryo transferred (Table II) . Mean fertilization rates in the different treatment groups ranged from both the culture and thawing of embryos. When embryos that were cultured and frozen in medium containing serum were 68-74% of oocytes inseminated, and were not significantly different. Embryo quality, measured as the proportion of thawed in medium containing NSA, the implantation rate was lower (6.1%), but this failed to reach statistical significance embryos which were suitable for either transfer or freezing, varied from 60-64% and was not affected by the type of (P ϭ 0.06). The results suggested that where NSA was used to supplement the media for either embryo culture and freezing protein supplement in the culture media.
Following the transfer of frozen/thawed embryos, both or for embryo thawing, then the potential of thawed embryos to establish a pregnancy was reduced. However the results pregnancy (P ϭ 0.0037) and implantation rates (P ϭ 0.0009) were significantly lower when NSA was used as the protein were confounded by significant differences between groups in post-thaw embryo survival (P ϭ 0.006) and the observation supplement in the thawing medium compared with serum (Table II) . Post-thaw embryo survival was similar in both that the highest survival (71%) occurred when serum was used for embryo culture and NSA for the thaw (Table IIIb) . groups; 61% when serum was used to supplement the thaw media, 64% with NSA.
To analyse the effect of NSA specifically during the initial embryo culture and freezing, all cycles where the medium To ascertain whether the adverse effect of NSA was localized to the thaw procedure all thaw cycles during the study period used for fertilization, culture and the freezing of suitable embryos was supplemented with NSA were matched to cycles were retrospectively analysed with respect to the type of protein used to supplement both the culture/freezing medium where serum was used to supplement the media used for embryo culture and freezing. The method of cycle pairing and the thaw medium. The results are presented in Table III. Clinical pregnancy rates were significantly different (P ϭ ensured that the type of treatment and the treatment outcomes were identical in both groups. There were no significant 0.0028) between the four combinations of protein supplementation (Table IIIa) . Pregnancy rates were significdifferences between the NSA and serum (control) cycles with respect to patient age, the number of oocytes recovered, antly lower (P ϭ 0.0011) when NSA replaced serum for the initial culture/embryo freezing medium, and the highest fertilization rates, number of embryos transferred or embryos frozen. The type of protein supplement used for the thawing pregnancy rate (18.2%) occurred when serum was used for both culture and thawing. When embryos which had been medium is not shown because of the small number of thaw cycles in the control group (n ϭ 5) where NSA was used to cultured and frozen in medium containing serum were thawed required to process sera on weekends, and this may have following routine IVF or the transfer of pronuclear embryos into the Fallopian tubes under laparoscopic control (ZIFT). In supplement the thawing medium. The outcome of frozen/ the present study the outcomes of both GIFT and ICSI cycles thawed embryos in these two groups of cycles has been were also shown to be unaffected by the use of NSA as a compared. To the end of 1995, 401 of the 770 embryos frozen protein supplement in the culture medium. in the NSA group (127 thaw cycles) and 400 of the 733
The effect of protein supplementation of culture media on embryos in the control cycles had been thawed (131 thaw frozen embryos has not been specifically addressed in previous cycles). The results are presented in Table IV. The pregnancy reports. In the study by Staessen et al. (1990) comparing rate in the control group (11.3%) was twice that in the NSA Albuminar-20 and serum supplementation, 63 thawed embryos group (5.6%), but this failed to reach statistical significance were transferred with approximately equal numbers of embryos (P ϭ 0.16). The implantation rate per embryo transferred was having been cultured in each medium but no pregnancy significantly lower in the NSA group (2.2% compared with resulted. Post-thaw embryo survival was low for both types 6.6%, P ϭ 0.049) and the implantation rate per embryo thawed of supplement (37%). Ours is the first report of a significant was also lower (P ϭ 0.03). Post-thaw embryo survival was effect of the type of protein used to supplement media for the similar in both groups (58% with NSA, 61% with serum).
culture, freezing and thawing of human embryos, on the clinical outcome following the transfer of thawed embryos. In our study, supplementing the thaw medium with NSA instead Discussion of autologous serum seemed to reduce both pregnancy and implantation rates but the effect was not statistically significant. The majority of couples chose to use their own serum rather than NSA to supplement the culture medium for either an Furthermore, it was shown that the viability of embryos cultured and frozen in medium containing NSA was significoocyte recovery or embryo thawing cycle. The inconvenience of using autologous serum is minimal for most couples, since antly reduced compared to embryos cultured and frozen in medium containing serum, irrespective of the type of protein for more than 90% of cycles, the additional blood is collected from the female partner at the time of a venepuncture for supplement used in the thaw medium. When the outcome of frozen embryos from cycles where hormonal monitoring. However, the differences between sites in the number of patients who were reluctant use NSA, and NSA was used in the culture medium was compared with that of embryos from matched control cycles, the implantation rate the decline in acceptance over time, suggest other factors influenced patient choice. Information provided to all couples was significantly lower in the NSA group; a corresponding difference in pregnancy rates did not reach statistical signiemphasized the possible advantages of using a standard protein supplement for fertilization and embryo culture media but ficance. If embryos cultured in the presence of NSA are more clearly the majority of couples were unconvinced and convenience was probably the most important factor influencing a susceptible to damage during freezing/thawing than those cultured in serum, then the outcome following the transfer of couple's decision to use NSA. This is supported by the observation that many couples changed their preference fresh embryos may not be affected but pregnancy rates for frozen/thawed embryos would be lower. Following freezing between cycles. Patient concern regarding the potential for cross-infection from 'foreign serum' or other factors possibly and thawing, in-vitro derived bovine embryos have lower viability than similar embryos recovered non-surgically on day influenced their attitude towards using NSA. At the unit with the higher level of acceptance the nursing staff were sometimes 7 or 8 after normal mating and development in vivo. Culture conditions, developmental stage and type of cryoprotectant of media supplemented with serum or NSA is similar but the concentration of carbohydrate in the NSA supplemented media affect post-thaw viability of embryos (Leibo and Loskutoff, 1993; Pollard and Leibo, 1994) . In the present study the is only about 10% that of serum. Protein supplements such as Plasmanate (Adler et al., 1993) or Plasmatein (Weathersbee outcome for frozen but not fresh embryos was affected by the inclusion of NSA instead of serum in the culture medium.
et al., 1995) contain significant amounts of glycoprotein in the form of α-and β-globulins and are reported to give satisfactory Furthermore, since embryo viability after freezing and thawing was lower when NSA was used to supplement the medium results following the transfer of fresh embryos. Pool and Martin (1994) obtained high pregnancy rates following IVF prior to freezing, NSA may have an indirect effect on postthaw embryo viability.
with Plasmatein as the medium supplement and suggested the beneficial effect of including glycoprotein components may The mechanism by which post-thaw embryo viability may be reduced in the presence of NSA remains speculative. NSA result from alterations in general physicochemical properties rather than specific effects. Carbohydrates such as dextran and is prepared from pooled human plasma by a cold ethanol extraction process and, like Albuminar, is available for clinical hydroxyethyl starch have cryoprotectant properties and are common components of many freezing solutions. Suppleuse as a 5% or 20% (w/v) protein solution. Purity is at least 95%, and the preparation contains 32 mmol octanoate, added menting freezing and thawing media with carbohydrate in the form of glycoproteins or carbohydrates such as hydroxyethyl to stabilize the albumin during the heat treatment process used to destroy any virus particles which may be present. starch or dextran, may overcome any negative effect of using media supplemented with NSA if indeed the low concentration During freezing embryos undergo extensive volumetric contraction due to dehydration. To protect against osmotic of carbohydrate is contributing to the poorer post-thaw viability of embryos frozen in medium containing NSA. damage during rehydration, osmotic buffers are added to the freezing and thawing solutions. Sucrose is commonly used but However, it remains possible that other factors may be important. Testart et al. (1986) reported high viability of frozen/ other non-permeable di-or monosaccharides could be added to the media (McWilliams et al., 1995) . While medium thawed human embryos cultured in Ménézo's B2 medium, a complex medium with highly purified bovine serum albumin composition will affect the exchange of water between the external medium and the embryo, any effects of serum or as the only protein source, and Queenan et al. (1994) obtained good implantation rates for pronuclear embryos frozen in NSA on reducing osmotic shock will be minor compared to those of including sucrose in the freezing and thawing media.
phosphate buffered saline apparently with no protein supplement and 1.5 M 1,2-propanediol as the cryoprotectant. The inclusion of macromolecules in the freeze/thaw solutions has been shown to reduce the size and nature of the extracellular
The power to detect a real difference in post-thaw embryo viability between embryos cultured and frozen in medium ice crystals which form during freezing (Solms and Rijke, 1971) . Staessen et al. (1990) showed no differences in postsupplemented with NSA and the matched controls from medium supplemented serum will increase as more of the thaw survival or development in vitro of mouse zygotes frozen in low concentrations of serum, bovine serum albumin or remaining embryos are thawed. The original NSA has recently been replaced by a more highly purified product, AlbumexAlbuminar-20. However, development in vitro to the blastocyst stage was dramatically reduced at higher (ϫ10) concentrations 20, which includes additional chromatographic steps in its preparation. Given the differences in embryo viability reported of bovine serum albumin or Albuminar-20. Dumoulin et al. (1994) showed that physical damage to mouse and human in this manuscript we have discontinued using NSA until the outcome for the remaining embryos is analysed. zonae pellucidae during freezing and thawing was significantly reduced when polymers were included in addition to the cryoprotectant 1,2-propanediol. Dextran, Ficoll and polyvinylpyrrolidone were equally effective, but the latter inhibited References further development of frozen-thawed two-cell mouse embryos.
